Skip to content

Clinical trials

Phase 2 Leiomyoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyoma Phase: Phase 2 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20064
20082
20101
20122
20141
20152
20161
20181
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated5
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Repros Therapeutics Inc.9
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Johns Hopkins University2
Bayer1
Meharry Medical College1
National Center for Complementary and Integrative Health (NCCIH)1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Thomas Jefferson University1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyoma19
Myofibroma2
Agnosia1
Fibroma1
Ileus1
Uterine Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.